| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―10 |
Impact of COVID-19 on Work Loss in the United States- A Retrospective Database Analysis |
Jennifer Judy, Alon Yehoshua, Julie Gouveia-Pisano, Richard A. Brook, Nathan L. Kleinman, Alek A. Drnach, Eric M. Rosenberg, Tanya Ghanjanasak, Deborah A. Winter, Feng Dai, Jannette M. Escobar, Heather Sell |
| 2 |
[GO] |
2024―Jan―31 |
Economic burden of COVID-19 for employers and employees in the United States |
Heather Sell, Kassandra Schaible, Julie A. Gouveia-Pisano, Alon Yehoshua, Deepa Malhotra, Manuela Di Fusco, Ashley S. Cha-Silva, Kathleen M Andersen, Lance Nicholls, Suzanne N. Landi, Catherine Rolland, Jennifer Judy |
| 3 |
[GO] |
2023―Dec―05 |
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA autumn 2023 vaccines in Germany |
K Joshi, S Scholz, M Maschio, M Kohli, A Lee, K Fust, B Ultsch, N vandeVelde, E Beck |
| 4 |
[GO] |
2023―Nov―28 |
COVID-19 vaccines should be evaluated from the societal perspective |
J P Sevilla |
| 5 |
[GO] |
2023―Nov―15 |
The impact of vaccination and outpatient treatment on the economic burden of covid-19 in the United States omicron era: a systematic literature review |
Vicki Pierre, Florin Draica, Manuela Di Fusco, Jingyan Yang, Solange Nunez-Gonzalez, Joanna Kamar, Santiago Lopez, Mary M Moran, Jennifer Nguyen, Piedad Alvarez, Ashley Cha-Silva, Meghan Gavaghan, Alon Yehoshua, Naomi Stapleton, Heather Burnett |
| 6 |
[GO] |
2023―Nov―14 |
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States |
Michele A. Kohli, Michael Maschio, Keya Joshi, Amy Lee, Kelly Fust, Ekkehard Beck, Nicolas Van de Velde, Milton C. Weinstein |
| 7 |
[GO] |
2023―Sep―22 |
Burden of COVID-19 during the omicron predominance in Brazil: a nationwide retrospective database study |
Jingyan Yang, Guilherme Cordeiro, Mauricio Longato, Shailja Vaghela, Moe H. Kyaw, Carlos Fernando Mendoza, Ana Dantas, Thais Senna, Pedro Holanda, Julia Regazzini Spinardi |
| 8 |
[GO] |
2023―Jun―09 |
The role of machine learning in healthcare responses to pandemics: maximizing benefits and filling gaps |
Ahmad Z. Al Meslamani, Anan S. Jarab, Mohammad A. Ghattas |
| 9 |
[GO] |
2023―Mar―21 |
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (original and omicron BA.4/BA.5) in the United States |
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, Timothy L. Wiemken, Jingyan Yang, Benjamin Yarnoff |
| 10 |
[GO] |
2023―Feb―22 |
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020 |
Nina Kim, Abdalla Aly, Chris Craver, W. Timothy Garvey |
| 11 |
[GO] |
2022―Oct―03 |
The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United States |
Michele A. Kohli, Michael Maschio, Amy Lee, Kelly Fust, Nicolas Van de Velde, Philip O. Buck, Milton C. Weinstein |
| 12 |
[GO] |
2022―Sep―13 |
Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021 |
Diana Mendes, Ruth Chapman, Peter Gal, Jessica Atwell, Jennifer L. Nguyen, Libby Hamson, Manuela Di Fusco, Carole Czudek, Jingyan Yang |
| 13 |
[GO] |
2022―May―16 |
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States |
Manuela Di Fusco, Kinga Marczell, Kristen A. Deger, Mary M. Moran, Timothy L. Wiemken, Alejandro Cane, Solène de Boisvilliers, Jingyan Yang, Shailja Vaghela, Julie Roiz |
| 14 |
[GO] |
2022―Apr―07 |
Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19 |
Scott Gibson, Rhodri Saunders, Nathan Stasko, Cherrishe-Brown Bickerstaff, John Oakley, Mark Osterman, Rafael Torrejon Torres, Jonathan K. Kish, Bruce A. Feinberg, David Emerson |
| 15 |
[GO] |
2022―Mar―16 |
COVID-19-associated hospitalizations among children less than 12 years of age in the United States |
Manuela Di Fusco, Shailja Vaghela, Mary M. Moran, Jay Lin, Jessica E. Atwell, Deepa Malhotra, Thomas Scassellati Sforzolini, Alejandro Cane, Jennifer L. Nguyen, Leah J. McGrath |
| 16 |
[GO] |
2022―Mar―15 |
How China controls the Covid-19 epidemic through public health expenditure and policy? |
Hui Jin, Baoyang Li, Mihajlo Jakovljevic |
| 17 |
[GO] |
2022―Feb―04 |
Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States |
Amie Scott, Richard Chambers, Maya Reimbaeva, Jessica Atwell, Nathalie Baillon-Plot, Florin Draica, Miriam Tarallo |
| 18 |
[GO] |
2022―Jan―17 |
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective |
Adrian Kilcoyne, Edward Jordan, Allen Zhou, Kimberly Thomas, Alicia N. Pepper, Dale Chappell, Miyuru Amarapala, Avery Hughes, Melissa Thompson |
| 19 |
[GO] |
2022―Jan―06 |
The societal economic value of COVID-19 vaccines in the United States |
Noam Kirson, Elyse Swallow, Jessica Lu, Marco Mesa-Frias, Brahim Bookhart, Josie Maynard, Yashna Shivdasani, Patrick Lefebvre |
| 20 |
[GO] |
2021―Nov―30 |
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2 |
Manuela Di Fusco, Mary M. Moran, Alejandro Cane, Daniel Curcio, Farid Khan, Deepa Malhotra, Andy Surinach, Amanda Miles, David Swerdlow, John M. McLaughlin, Jennifer L. Nguyen |
| 21 |
[GO] |
2021―Aug―06 |
Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis |
William V. Padula, Shreena Malaviya, Natalie M. Reid, Benjamin G. Cohen, Francine Chingcuanco, Jeromie Ballreich, Jonothan Tierce, G. Caleb Alexander |
| 22 |
[GO] |
2021―Feb―13 |
Health outcomes and economic burden of hospitalized COVID-19 patients in the United States |
Manuela Di Fusco, Kimberly M Shea, Jay Lin, Jennifer L Nguyen, Frederick J Angulo, Michael Benigno, Deepa Malhotra, Birol Emir, Anita H Sung, Jennifer L Hammond, Sophia Stoychev, Apostolos Charos |
| 23 |
[GO] |
2020―Nov―30 |
Iran, sanctions, and the COVID-19 crisis |
Amir Abdoli |
|
